Haematology Diseases
Skåne University Hospital have a long history of treating patients with advanced blood and immune system diseases. We provide highly specialized care for conditions such as leukemia, lymphoma, myeloma, and other disorders affecting the bone marrow.
One of our core areas of expertise is hematopoietic stem cell transplantation (HSCT). Transplantation is performed using stem cells from a suitable donor, which may be a fully HLA-matched sibling, a well-matched unrelated donor, or, in many cases, a half-matched (haploidentical) family member. Since 1998, we have successfully performed haploidentical HSCT, making transplantation possible for almost all patients who are medically eligible. Our stem cell transplantation programme is internationally accredited by JACIE, reflecting the highest standards of quality and patient safety.
Starting in 2022, Skåne University Hospital also offers CAR-T cell therapy, an advanced form of immunotherapy. CAR-T therapy involves reprogramming a patient’s own immune cells to recognize and attack cancer cells and is used for selected patients with certain types of lymphoma and leukemia. This highly specialized treatment is provided by an experienced multidisciplinary team in a closely monitored hospital setting.
As a university hospital affiliated with Lund University, our hematologists and oncologist combine advanced clinical care with cutting-edge research, ensuring the latest scientific advances are quickly and safely translated into patient treatment. work ensuring that the latest scientific research is rapidly translated into clinical practice.
Since 2020, Skåne University Hospital has served as the operational center for all Icelandic patients requiring allogeneic stem cell transplantation, further underscoring our role as a trusted referral center for advanced hematological care.